Ramiro Ribeiro
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Ramiro Ribeiro is currently Chief Medical Officer at EyePoint, Inc. since 2024.
Formerly, Dr. Ribeiro was Vice President & Head-Clinical Development at Apellis Pharmaceuticals, Inc. from 2018 to 2024.
Education includes doctorates from Universidade Federal De Sao Paulo and Pontificia Universidade Catolica Do Parana.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EYEPOINT, INC. -.--% | 21/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| EYEPOINT, INC. | Directeur Technique/Scientifique/R&D | 04/03/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2024 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Pontificia Universidade Catolica Do Parana
Pontificia Universidade Catolica Do Parana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidade Federal De Sao Paulo
Universidade Federal De Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national